Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 289068, 6 pages
http://dx.doi.org/10.1155/2009/289068
Research Article

Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV

1Department of Cancer Research, Key Laboratory of Molecular Microbiology and Technology of Ministry of Education, Institute for Molecular Biology, College of Life Sciences, Nankai University, Tianjin 300071, China
2Department of Biochemistry, College of Life Sciences, Nankai University, Tianjin 300071, China

Received 5 February 2009; Accepted 16 July 2009

Academic Editor: Xin-yuan Guan

Copyright © 2009 Hang Zhang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. X. Zhang, H. Zhang, and L. Ye, “Effects of hepatitis B virus X protein on the development of liver cancer,” Journal of Laboratory and Clinical Medicine, vol. 147, no. 2, pp. 58–66, 2006. View at Publisher · View at Google Scholar
  2. X. Zhang, W. Zhang, and L. Ye, “Pathogenesis of hepatitis B virus infection,” Future Virology, vol. 1, no. 5, pp. 637–647, 2006. View at Publisher · View at Google Scholar
  3. B. J. McMahon, “Epidemiology and natural history of hepatitis B,” Seminars in Liver Disease, vol. 25, supplement 1, pp. 3–8, 2005. View at Publisher · View at Google Scholar
  4. X. Zhang, N. Dong, L. Yin et al., “Hepatitis B virus X protein upregulates survivin expression in hepatoma tissues,” Journal of Medical Virology, vol. 77, no. 3, pp. 374–381, 2005. View at Publisher · View at Google Scholar
  5. H.-W. L. Hann, J. Lee, A. Bussard et al., “Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma,” Cancer Research, vol. 64, no. 20, pp. 7329–7335, 2004. View at Publisher · View at Google Scholar
  6. M. Levrero, M. Stemler, C. Pasquinelli et al., “Significance of anti-HBx antibodies in hepatitis B virus infection,” Hepatology, vol. 13, no. 1, pp. 143–149, 1991. View at Publisher · View at Google Scholar
  7. L. Vitvitski-Trepo, A. Kay, C. Pichoud et al., “Early and frequent detection of HBxAg and/or anti-HBx in hepatitis B virus infection,” Hepatology, vol. 12, no. 6, pp. 1278–1283, 1990. View at Publisher · View at Google Scholar
  8. J. Pál, Z. Nyárády, I. Marczinovits et al., “Comprehensive regression analysis of hepatitis B virus X antigen level and anti-HBx antibody titer in the sera of patients with HBV infection,” Pathology and Oncology Research, vol. 12, no. 1, pp. 34–40, 2006. View at Publisher · View at Google Scholar
  9. G.-Y. Hwang, C.-Y. Lin, L.-M. Huang et al., “Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma,” Journal of Clinical Microbiology, vol. 41, no. 12, pp. 5598–5603, 2003. View at Publisher · View at Google Scholar
  10. J. Pál, C. Somogyi, A. Szmolenszky et al., “Immunohistochemical assessment and prognostic value of hepatitis B virus X protein in chronic hepatitis and primary hepatocellular carcinomas using anti-HBxAg monoclonal antibody,” Pathology and Oncology Research, vol. 7, no. 3, pp. 178–184, 2001. View at Google Scholar
  11. J. Pál, T. Czömpöly, Z. Nyárády et al., “Determination of the fine epitope specificity of an anti-hepatitis B virus X protein monoclonal antibody using microanalytical and molecular biological methods,” Molecular Immunology, vol. 40, no. 5, pp. 241–246, 2003. View at Publisher · View at Google Scholar
  12. J. Pál, L. Pálinkás, Z. Nyárády et al., “Sandwich type ELISA and a fluorescent cytometric microbead assay for quantitative determination of hepatitis B virus X antigen level in human sera,” Journal of Immunological Methods, vol. 306, no. 1-2, pp. 183–192, 2005. View at Publisher · View at Google Scholar
  13. C.-T. Yeh, C.-H. Shen, D.-I. Tai, C.-M. Chu, and Y.-F. Liaw, “Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma,” Oncogene, vol. 19, no. 46, pp. 5213–5220, 2000. View at Google Scholar
  14. G. G. Chen, M. Y. Li, R. L. K. Ho, E. C. W. Chak, W. Y. Lau, and P. B. S. Lai, “Identification of hepatitis B virus X gene mutation in Hong Kong patients with hepatocellular carcinoma,” Journal of Clinical Virology, vol. 34, no. 1, pp. 7–12, 2005. View at Publisher · View at Google Scholar
  15. P. Zhu, D. Tan, Z. Peng, F. Liu, and L. Song, “Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from Southern China,” Acta Biochimica et Biophysica Sinica, vol. 39, no. 4, pp. 265–272, 2007. View at Publisher · View at Google Scholar
  16. W. Lu, H. Takahashi, B. Furusato et al., “Allelotyping analysis at chromosome arm 8p of high-grade prostatic intraepithelial neoplasia and incidental, latent, and clinical prostate cancers,” Genes Chromosomes and Cancer, vol. 45, no. 5, pp. 509–515, 2006. View at Publisher · View at Google Scholar
  17. R. M. Ribeiro, A. Lo, and A. S. Perelson, “Dynamics of hepatitis B virus infection,” Microbes and Infection, vol. 4, no. 8, pp. 829–835, 2002. View at Publisher · View at Google Scholar
  18. R. S. Tedder, S. Ijaz, N. Gilbert et al., “Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers,” Journal of Medical Virology, vol. 68, no. 4, pp. 505–512, 2002. View at Publisher · View at Google Scholar
  19. V. Kumar, N. Jayasuryan, H. Reddi, D. Sahal, and S. K. Panda, “A monoclonal antibody against the X protein of hepatitis B virus: fine mapping of its epitope and application in a quantitative ELISA of the X protein in sera of hepatitis B patients,” Hybridoma, vol. 17, no. 2, pp. 157–164, 1998. View at Google Scholar
  20. E. B. Keeffe, D. T. Dieterich, S. B. Han et al., “A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update,” Clinical Gastroenterology and Hepatology, vol. 4, no. 8, pp. 936–962, 2006. View at Publisher · View at Google Scholar
  21. H. Y. Ali, “Trial of lamivudine in hepatitis B surface antigen carriers with persistent hepatitis B core IgM antibody,” Saudi Medical Journal, vol. 24, no. 9, pp. 996–999, 2003. View at Google Scholar
  22. T. Chen, J. M. Luk, S.-T. Cheung, W.-C. Yu, and S.-T. Fan, “Evaluation of quantitative PCR and branched-chain DNA assay for detection of hepatitis B virus DNA in sera from hepatocellular carcinoma and liver transplant patients,” Journal of Clinical Microbiology, vol. 38, no. 5, pp. 1977–1980, 2000. View at Google Scholar
  23. R. M. Gordillo, J. Gutierrez, and M. Casal, “Evaluation of the COBAS TaqMan 48 real-time PCR system for quantitation of hepatitis B virus DNA,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3504–3507, 2005. View at Publisher · View at Google Scholar
  24. J. Lupberger and E. Hildt, “Hepatitis B virus-induced oncogenesis,” World Journal of Gastroenterology, vol. 13, no. 1, pp. 74–81, 2007. View at Google Scholar
  25. J.-M. Huang, T.-H. Huang, H.-Y. Qiu, X.-W. Fang, T.-G. Zhuang, and J.-W. Qiu, “Studies on the integration of hepatitis B virus DNA sequence in human sperm chromosomes,” Asian Journal of Andrology, vol. 4, no. 3, pp. 209–212, 2002. View at Google Scholar
  26. A. Tamori, S. Nishiguchi, S. Kubo et al., “HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan,” Journal of Medical Virology, vol. 71, no. 4, pp. 492–498, 2003. View at Publisher · View at Google Scholar
  27. H.-P. Huang, D.-J. Tsuei, K.-J. Wang et al., “Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 20, no. 8, pp. 1206–1214, 2005. View at Publisher · View at Google Scholar
  28. D. K.-H. Wong, M.-F. Yuen, R. T.-P. Poon, J. C.-H. Yuen, J. Fung, and C.-L. Lai, “Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma,” Journal of Hepatology, vol. 45, no. 4, pp. 553–559, 2006. View at Publisher · View at Google Scholar